Lantheus Holdings Inc
NASDAQ:LNTH

Watchlist Manager
Lantheus Holdings Inc Logo
Lantheus Holdings Inc
NASDAQ:LNTH
Watchlist
Price: 62.27 USD -1.63% Market Closed
Market Cap: 4.1B USD

During the last 3 months Lantheus Holdings Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 13% over this period (open performance analysis).

The last transaction was made on Aug 20, 2025 by Wehrly Mark C , who sold 188.9m USD worth of LNTH shares.

Last Transactions:
Wehrly Mark C
$-188.9m
Farallon Partners L L C/Ca
$-188.9m
Wehrly Mark C
$-2.3m
Farallon Partners L L C/Ca
$-2.3m
Blanchfield Paul
$-163.9k
Niedzwiecki Daniel
$-472.4k
Marshall Robert J. Jr.
$-284k
Mchugh Julie
$-423.8k
Blanchfield Paul
$-525.6k
Niedzwiecki Daniel
$-477.9k
Heino Mary Anne
$-235.2k
Marshall Robert J. Jr.
$-1m
Heino Mary Anne
$-200.3
Blanchfield Paul
$-204.2k
Heino Mary Anne
$-578.2k
Thrall James H
$-94.8k
Marshall Robert J. Jr.
$-812k
Blanchfield Paul
$-159.3k
Heino Mary Anne
$-646.3k
Thrall James H
$-98.5k
Niedzwiecki Daniel
$-243.9k
Ber Gerard
$-1.1m
Blanchfield Paul
$-192.8k
Heino Mary Anne
$-640.1k
Sabens Andrea
$-224.4k
Sabens Andrea
$-42k
Pruden Gary J
$-1.2m
Sabens Andrea
$-27.2k
Heino Mary Anne
$-81.3
Blanchfield Paul
$-95.3k
Niedzwiecki Daniel
$-1m
Maeusli Heinz Christoph
$-544
View All Transactions

During the last 3 months Lantheus Holdings Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 13% over this period (open performance analysis).

The last transaction was made on Aug 20, 2025 by Wehrly Mark C , who sold 188.9m USD worth of LNTH shares.

Sold
0-3
months
0 USD
0
3-6
months
383.1m USD
4
6-9
months
3m USD
5
9-12
months
877.2k USD
3
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD

Lantheus Holdings Inc
Insider Trading Chart

Lantheus Holdings Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Lantheus Holdings Inc
Last Insider Transactions

Global
Insiders Monitor

Lantheus Holdings Inc
Glance View

Lantheus Holdings Inc. is a captivating player in the healthcare sector, primarily operating within the niche of diagnostic medical imaging. The company's core mission revolves around enhancing diagnosis and treatment pathways, thus playing an integral role in patient care. At the heart of Lantheus's operations are its innovative diagnostic and therapeutic products, including radiopharmaceuticals and contrast agents that physicians rely on to obtain detailed images of the body's organs and tissues. Through a combination of proprietary technologies and strategic partnerships, Lantheus delivers solutions that help medical professionals make more informed clinical decisions, ultimately aiming to improve patient outcomes. This business generates revenue by developing, manufacturing, and commercializing its products, which are utilized across hospitals, clinics, and research centers worldwide. By consistently investing in research and development, Lantheus ensures a competitive edge through a robust pipeline of next-generation imaging agents. Strategic alliances and collaborative ventures further fortify its market presence, allowing the company to expand its reach and integrate new advancements into its product offerings. This commitment to innovation and collaboration has not only cemented its reputation in the life sciences industry but also ensures a steady and growing stream of income from its well-regarded product lines.

LNTH Intrinsic Value
99.91 USD
Undervaluation 38%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top